Science and Research Team

The Science and Research Team at Abdera Therapeutics focuses on the development and optimization of targeted alpha therapies (TATs) for treating relapsed, refractory, and metastatic cancers. This team conducts rigorous research, including analytical chemistry, to innovate and refine purpose-built vectors for delivering high-energy radio-isotopes to tumors and metastatic cancer lesions. Their work is pivotal in advancing Abdera’s mission to introduce a new class of drugs with significant therapeutic and commercial potential in the oncology sector.